Other languages Geron Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
3.93 ^USD	-0.51%		+3.69%	+86.26%

May. 03	Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating	MT
May. 02	Geron Shares Decline After Q1 Loss Widens	MT

Geron Shares Decline After Q1 Loss Widens	May. 02
Geron Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants	Mar. 19
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 15
Sector Update: Health Care Stocks Softer Friday Afternoon	Mar. 15
Sector Update: Health Care	Mar. 15
Top Midday Gainers	Mar. 15
Geron Shares Soar on Positive FDA Advisory Panel's Vote on Imetelstat for Blood Disorder	Mar. 15
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 15
Sector Update: Health Care	Mar. 15
Investors Turn Cautious Ahead of Next Week's Fed Meeting, Stifling US Equity Futures Pre-Bell	Mar. 15
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Rate Cut Hopes Wane	Mar. 15
Top Premarket Gainers	Mar. 15
Geron Corporation Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS	Mar. 14
Geron's blood disorder drug gets FDA advisers' backing	Mar. 14
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 12
Sector Update: Health Care	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting; Shares Slump	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting	Mar. 12
US FDA staff flags concerns about Geron's anemia treatment	Mar. 12

No results for this search